Clinical study of t-PA and u-PA expression in breast cancer

WU Fang,QU Bin,WANG Xue-Feng,WANG Hong-Li
2006-01-01
Tumor
Abstract:Objective:To detect the mRNA expression and plasma content of fibrinolysis molecular markers in patients with breast cancer and to elucidate their relationship with tumor invasion and metastasis and clinical significance. Methods:The mRNA expression of tissue-type plasminogen activator (t-PA), urokinase-type plasminogen activator (u-PA) in 30 breast cancer tissues was determined by reverse transcriptase-real time polymerase chain reaction. The plasma content of fibrinolysis molecular markers such as t-PA,u-PA, urokinase-type plasminogen activator receptor (u-PAR), and plasmin anti-plasmin complex (PAP) were measured by ELISA. Results:The plasma levels of u-PA,u-PAR,and PAP were elevated in breast cancer patients compared with normal control. The plasma level of u-PA was remarkably elevated in patients with lymph node involvement or distal metastasis. Expression of u-PA mRNA increased in breast cancer tissues compared with normal control. The difference was significant between different clinical stages. Expression of t-PA mRNA decreased in breast cancer tissues compared with normal control. It was significantly higher in estrogen receptors (ER)- and progesterone receptors (PR)-double positive group. Conclusion:Hyperfibrinolysis was an important factor related with the potential of invasion and metastasis of breast cancer. With the help of reverse transcriptase-real time quantitative PCR,t-PA and u-PA mRNA could be used as the assistant markers for supervision of breast cancer, evaluation of prognosis, and selection of therapeutic regimen.
What problem does this paper attempt to address?